Table 2.
Structural advances in 3D bioprinting of skin.
Classifications | Materials | Cell Components (Origin) | Printing Methods | Printability (Fidelity) and Scalability | Biological Assessment of Printed Constructs | Advantages (+) Challenges (−) |
Ref. |
---|---|---|---|---|---|---|---|
Hair | GelMA and HAMA | NHDFs (human dermis), HaCaT cells (human epidermis), and HFDPCs (human scalp) | Extrusion | Triple-layered micron-sized lattice structure |
|
+ A papillary layer was recapitulated by 3D printing. + Enhanced epidermis-dermis interaction supported spontaneous hair pore development. − Long-term observation is required for full hair shaft development. |
[23] |
GelMA and rhCol3 | HaCaT cells and HDFs (human skin) | Extrusion | Filament fusion test at millimeter scales |
|
+ rhCol3 enhanced the growth of HaCaT cells and HDFs. + Enhanced wound healing and hair follicle development on in vivo rat model. − higher cell spreading and population in dermal layers are required. |
[78] | |
Col | KCs (human neonatal foreskin dermis), HUVECs (human umbilical cord), and HFDPCs (human scalp) | Extrusion | Micropillar mold 500 μm in diameter and 4 mm in length |
|
+ The HFU-developed and vascularized dermal constructs were fabricated. + The skin engraftment allows for human hair growth in nude mice. − Reproducibility on hair shaft protrusion should be confirmed. |
[79] | |
Vascularization | PGA, and xeno-free dermal and epidermal bioink | HECs (umbilical cord blood), FBs (human dermis), PCs (human placentas), and KCs (human epidermis) | Extrusion | NA |
|
+ A mature stratified epidermis with rete ridge-like structures was developed. + The developed microvessels prevented graft necrosis and induced perfusion with host microvessels. + A xeno-free approach to complex tissue engineering was achieved. − Further studies are required on the efficacy of the xeno-free strategy and the degree of wound bed contraction. |
[80] |
GelMA, SCS, and DA | BMSCs, HUVECs, NHDFs, and HaCaT cells (from human origin) | Extrusion | Lattice-structured constructs |
|
+ Micro-vascularization as tubelike structures with endothelial cell marker expression were confirmed. + Enhanced in vitro skin wound healing activity and maintained multipotency of BMSCs. − Further biological evaluations are required. |
[81] | |
GelMA, HA-NB, and LAP | HFBs and HUVECs (from human origin) | DLP | Cylinder with submicron lattices |
|
+ The DLP enabled interconnected microchannel formation that facilitates cellular behaviors. + Efficient neovascularization was achieved by mimicking the physiological structure of native skin. + Induced instant defense function and dermal regeneration with skin appendages in large animals. − In-depth studies on underlying mechanisms in the hair follicle and blood vessel regeneration are required. |
[82] | |
Rat tail Col I | HFBs, HUVECs, HECFCs, PCs, and HKCs (from human origin) | Extrusion | NA |
|
+ In vitro, HKCs formed a multilayered barrier, while the HUVECs and PCs self-assemble into interconnected microvascular networks. + Transplantable skin grafts composed of an irrigational microvascular system were developed. − Harvesting plenty of healthy cells from the patients are required. |
[83] | |
Full thickness | Gel, glycerol, and HA | KCs, dark melanocytes, HDFs, HFDPCs, HDMECs, and preadipocytes (from human origin) | Extrusion | 2.5 × 2.5 cm triple-layered patch with micron-sized lattices |
|
+ Epidermis-dermis-hypodermis triple−layered skin mimetics were 3D bioprinted. + Matured normal and basket weave Col was observed. − Immune responses in the large animal models should be elucidated. |
[84] |
GelMA and Alg | HDFs (human dermis), HUVECs (human umbilical cord), HKCs | Extrusion | Micron-sized lattice |
|
+ A 3D full-thickness skin model composed of epidermis-dermis with vasculature was fabricated. + Controlled matrix stiffness regulated pro−Col1α1 and MMP-1 expression. + Repeated HKCs seeding and Gel coating support epidermal differentiation. − Epidermal markers should be further elucidated. |
[85] | |
Alg, Gel, and DCEL | FBs (human dermis) and KCs (human epidermis) | Extrusion | Micron-sized highly fine lattice-structured cylinder |
|
+ The incorporated DCEL can induce the uniform distribution of cellulose fibers within bioinks. + The distinct epidermal-dermal histological features were visualized with specific marker expressions. − Further biological assessments should be conducted. |
[86] | |
Col | HDFs (human neonatal dermis), HKCs (human neonatal epidermis), and MCs (human darkly pigmented neonatal epidermis) | Extrusion | 2 × 2 cm stratified constructs |
|
+ KC formed the stratum corneum and freckle-like pigmentations were developed by MCs at the dermal-epidermal junction. + First developed engineered ephelides in biomimetic skin. −In−depth studies for melanin production and pigmentation should be conducted. |
[87] | |
Gel, Col I, elastin, fibrinogen, laminin, and entactin | HDF (neonatal human dermis) and HKCs (neonatal human epidermis) | Extrusion | Directly 3D printed on a well plate. |
|
+ Four primary layers of the epidermis were developed. + Stratum granulosum formed f-TKD shape allowing homeostasis by tight junction barrier. − Need to apply iPSCs to obtain consistent and reproducible KCs sources. |
[88] |
Abbreviations: ARS, Alizarin red S; BMSC, bone marrow-derived stem cells; DA, dextran aldehyde; DCEL, diethylaminoethyl cellulose; DLP, digital light processing; GelMA, Gel methacryloyl; HAMA, hyaluronic acid (HA) methacryloyl; HA-NB, NB-linked HA; HDMECs, human dermal microvascular endothelial cells, HECFCs human endothelial colony-forming cells; HECs, human endothelial cells; HFDPCs, hair follicle dermal papilla cells; HFU, hair follicle unit; HKCs, human KCs; IHC, immunohistochemical; iPSCs, induced pluripotent stem cells; LAP, lithium phenyl-2,4,6-trimethylbenzoylphosphinate; MCs, melanocytes; MMP, matrix metalloproteinase; NB, N-(2-aminoethyl)-4-(4-(hydroxymethyl)-2-methoxy-5-nitrosophenoxy) butanamide; NHEKs, normal human epithelial KCs; OCT, optical coherence tomography; PCs, placental pericytes; rhCol, recombinant human Col; SCS, succinylated chitosan; and SKPs, skin-derived precursors.